 
        Minimal benefit of annually repeated PRP injection in knee OA vs. non-recurring treatment
 
                                                    Minimal benefit of annually repeated PRP injection in knee OA vs. non-recurring treatment
The effects of repeated intra-articular PRP injections on clinical outcomes of early osteoarthritis of the knee
Knee Surg Sports Traumatol Arthrosc. 2015 Aug;23(8):2170-7.Synopsis
93 patients with early-stage osteoarthritis (OA) of the knee were randomized to receive either a single cycle of platelet-rich plasma (PRP) treatment consisting of 3 injections, or to receive the same treatment plus an additional second cycle, repeated 1 year later. Patients were followed-up for a minimum of 2 years after initiation of treatment. The purpose of the study was to determine if annual...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
             
                        
Join the Conversation
Please Login or Join to leave comments.